Literature DB >> 27594084

Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists.

Stergios A Polyzos1, Elisabetta Bugianesi2, Jannis Kountouras3, Christos S Mantzoros4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27594084     DOI： 10.1016/j.metabol.2016.08.001

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  3 in total

1.  Inflammation is independent of steatosis in a murine model of steatohepatitis.

Authors:  Wei Wang; Ming-Jiang Xu; Yan Cai; Zhou Zhou; Haixia Cao; Partha Mukhopadhyay; Pal Pacher; Shusen Zheng; Frank J Gonzalez; Bin Gao
Journal:  Hepatology       Date:  2017-05-18       Impact factor: 17.425

2.  Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD).

Authors:  Stergios A Polyzos; Christos S Mantzoros
Journal:  Metabolism       Date:  2020-07-21       Impact factor: 8.694

Review 3.  Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease.

Authors:  Chrysoula Boutari; Nikolaos Perakakis; Christos Socrates Mantzoros
Journal:  Endocrinol Metab (Seoul)       Date:  2018-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.